In the United States, in the state of Missouri, Republican Governor Mike Parson on Tuesday (June 7th) affixed his signature to a text of law which will prohibit the medical homologation commissions of the American states from sanctioning or withdrawing the license to practice. medicine to doctors who prescribe ivermectin or hydroxychloroquine to patients infected with Covid-19, reports Kaiser Health News.
The measure, which will take effect in August, passed Tuesday after being approved by the Legislative Assembly in May. This law will also prohibit pharmacists from contacting a doctor or a patient to contest the effectiveness of these drugs and question the prescription issued. A way for the Missouri legislature to protect doctors’ prescribing freedom
“Restoring the balance between pharmacists and doctors”
This legislation, which was added as an amendment to a package of changes to medical licensing regulations, was sponsored by Senator Rick Brattin (Republican). The latter reports that doctors are worried about the potential repercussions by prescribing the two molecules: “They feared losing their license to practice if they were denounced”, explained Tuesday the politician, who underlines: “They wanted that something to be done about it. “And to affirm: “Some pharmacists wanted to take on the role of doctors and refused to issue these prescriptions. This restores the professional balance between doctors and pharmacists”.
In addition, the Republican believes that the two drugs have been the subject of “politicization” during the Covid-19 crisis.
Missouri State Rep. Patty Lewis earlier said Democrats agreed to the bill’s wording to satisfy a “far-right conservative group” in the Senate.
Ivermectin and hydroxychloroquine, two drugs against Covid-19 denigrated by the FDA
Ivermectin, an antiparasitic used primarily in animals to treat parasitic worms, is also for humans, used to treat cases of intestinal strongyloidiasis and onchocerciasis, two conditions caused by parasitic worms, or external parasites such as lice and skin conditions such as rosacea, but not Covid-19, according to the Food and Drug Administration (FDA), the United States equivalent of the French Health Products Safety Agency.
“You are not a horse. You are not a cow. Seriously, y’all, stop with that! “, she had tweeted in August 2021.
You are not a horse. You are not a cow. Seriously, y’all. Stop it. https://t.co/TWb75xYEY4
— U.S. FDA (@US_FDA) August 21, 2021
Regarding hydroxychloroquine, the FDA in July 2020 said it had no benefit in reducing the likelihood of death or accelerating recovery from Covid-19.
Statements that are far from unanimous within the scientific community. At the end of May, we received Dr. Flavio Cadegiani, a Brazilian endocrinologist, who confided to us during a debriefing that the studies on ivermectin were biased and that the performance of the drug in terms of reducing mortality linked to Covid-19 was actually established at 94.6%.
See also: Dr Cadegiani: ivermectin shows exceptional performance (94.6% reduction in Covid mortality)
As for the other drug, Professor Didier Raoult, an eminent specialist in infectious diseases recognized worldwide, reported again on 1is June that there were now two articles published by the teams of the IHU Marseille demonstrating the “very significant” effectiveness of the hydroxychloroquine / azithromycin treatment in their center, in a day hospital, including one including 10,429 patients.
Two articles now published by our teams report the treatment of patients. They very significantly show the effectiveness of hydroxychloroquine / azithromycin treatment in our center, in a day hospital (10,429 patients) https://t.co/8wIrzKMpon
(1/2)— Didier Raoult (@raoult_didier) June 1, 2022